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Gene-targeted deletion of the potassium channel Kv1.3 (Kv1.3−/−) results in
“Super-smeller” mice with a sensory phenotype that includes an increased olfactory
ability linked to changes in olfactory circuitry, increased abundance of olfactory cilia,
and increased expression of odorant receptors and the G-protein, Golf. Kv1.3
−/− mice
also have a metabolic phenotype including lower body weight and decreased adiposity,
increased total energy expenditure (TEE), increased locomotor activity, and resistance to
both diet- and genetic-induced obesity. We explored two cellular aspects to elucidate
the mechanism by which loss of Kv1.3 channel in the olfactory bulb (OB) may enhance
glucose utilization and metabolic rate. First, using in situ hybridization we find that
Kv1.3 and the insulin-dependent glucose transporter type 4 (GLUT4) are co-localized
to the mitral cell layer of the OB. Disruption of Kv1.3 conduction via construction of
a pore mutation (W386F Kv1.3) was sufficient to independently translocate GLUT4 to
the plasma membrane in HEK 293 cells. Because olfactory sensory perception and
the maintenance of action potential (AP) firing frequency by mitral cells of the OB
is highly energy demanding and Kv1.3 is also expressed in mitochondria, we next
explored the structure of this organelle in mitral cells. We challenged wildtype (WT) and
Kv1.3−/− male mice with a moderately high-fat diet (MHF, 31.8 % kcal fat) for 4 months
and then examined OB ultrastructure using transmission electron microscopy. In WT
mice, mitochondria were significantly enlarged following diet-induced obesity (DIO) and
there were fewer mitochondria, likely due to mitophagy. Interestingly, mitochondria were
significantly smaller in Kv1.3−/− mice compared with that of WT mice. Similar to their
metabolic resistance to DIO, the Kv1.3−/− mice had unchanged mitochondria in terms
of cross sectional area and abundance following a challenge with modified diet. We are
very interested to understand how targeted disruption of the Kv1.3 channel in the OB
can modify TEE. Our study demonstrates that Kv1.3 regulates mitochondrial structure
and alters glucose utilization; two important metabolic changes that could drive whole
system changes in metabolism initiated at the OB.
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INTRODUCTION
There aremultifarious roles for potassium channels beyond being
drivers of the resting potential (Kaczmarek, 2006), although
classically potassium channels are dampeners of excitability
through timing of the interspike interval and shaping of the
action potential (AP; Jan and Jan, 1994; Yellen, 2002). Among the
non-conductive functions of potassium channels lies their ability
to detect, be regulated, or be modulated by energy substrates or
metabolites, namely glucose, ATP, or NADPH (Pan et al., 2011;
Tucker et al., 2013; Tinker et al., 2014). This original research
article will present a review of metabolic sensing by a brain region
outside the traditional endocrine axis controlling food intake
and energy balance—the olfactory bulb (OB). We highlight the
role of a particular potassium channel, Kv1.3, which is highly
expressed in the OB and may serve as the molecular sensor of
metabolism. We hypothesize that the olfactory system has a dual
function, to transduce external chemical signals, or odorants,
into an internal representation, and simultaneously to detect
internal chemistry, namely metabolically important molecules,
such as glucose and insulin (Fadool et al., 2000, 2011; Tucker
et al., 2013). Thus, the OB is a detector of metabolic state;
the biophysical properties of Kv1.3 are modulated by energy
availability and the disruption of energy homeostasis can modify
olfactory sensory coding (Palouzier-Paulignan et al., 2012). Such
metabolic sensing could change food intake given the intimate
relationship of olfactory perception to satiety and food choice
(Aime et al., 2007; Tong et al., 2011; Badonnel et al., 2014;
Soria-Gomez et al., 2014; Lacroix et al., 2015). We summarize
current data leading to the glucose-sensing ability of Kv1.3-
expressing neurons in the OB and present new data showing
the expression of glucose transporter type 4 (GLUT4) in the
OB. We report biochemical evidence that Kv1.3 activity can alter
GLUT4 translocation, and demonstrate ultrastructural changes
in the OB mitochondria of Kv1.3−/− mice. To place our new
studies in context, we will (1) describe the phenotype of Kv1.3−/−
mice and the role of this voltage-dependent channel in olfaction,
(2) discuss the potential therapeutic benefits of targeting Kv1.3
channels centrally and peripherally for energy homeostasis, (3)
present the known distribution and role of glucose transporters
in the OB, (4) summarize the known expression of Kv1.3 in
mitochondria, and (5) conclude the introduction by describing
Abbreviations: AP, action potential; ATP, adenosine triphosphate; AVMA,
American Veterinary Medical Association; BSA, bovine serum albumin; CF,
control diet; CMV, cytomegalovirus; ddH2O, double-distilled water; DIO, diet-
induced obesity; EtOH, ethanol; FSU, Florida State University; GCCP, Guidance
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transporter type 4; h, hour; HEK, human embryonic kidney; IACUC, Institutional
Animal Care and Use Committee; IMM, inner mitochondrial membrane; IP,
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channel 1.3; MEM, minimal essential medium; MHF, moderately high-fat diet;
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phosphate; NIH, National Institutes of Health; NTMT, alkaline phosphatase buffer;
OB, olfactory bulb; OMM, outer mitochondrial membrane; OR, olfactory receptor;
OSN, olfactory sensory neuron; PBS, phosphate-buffered saline; PBST, phosphate-
buffered saline + Tween; PFA, paraformaldehyde; PG, periglomerular; PKA,
protein kinase A; PKC, protein kinase C; PPI, phosphatase inhibitor; ROS, reactive
oxygen species; SDS, sodium dodecyl sulfate; snk, Student Newman Keuls post-hoc
test; SSC, saline sodium citrate; TEE, total energy expenditure; WT, wildtype.
recent data that demonstrate the impact of metabolic imbalance
on the structure/function of the OB.
The discovery of the many non-conductive roles for Kv1.3
was made through loss of function studies using a whole-animal,
targeted deletion of the Kv1.3 gene (Koni et al., 2003). We
and other laboratories identified the Kv1.3−/− mice as thinner
than their wild-type (WT) counterparts without caloric self-
restriction (Xu et al., 2003, 2004; Fadool et al., 2004). The mice
had lower plasma fasting glucose levels, lower leptin levels,
and had greater insulin sensitivity when challenged with an
intraperitoneal glucose tolerance test (Xu et al., 2003; Tucker
et al., 2008, 2010; Thiebaud et al., 2014). Using a custom-
designed metabolic chamber to quantify systems physiology
parameters and ingestive behaviors (Williams et al., 2003), we
found that the Kv1.3−/− mice ate frequent small meals and
drank large boluses of water while still maintaining identical
total caloric and water intake as that of WT animals (Fadool
et al., 2004). Kv1.3−/− mice showed slightly elevated metabolic
activity (Xu et al., 2003; Fadool et al., 2004) and increased
locomotor activity, particularly in the dark cycle (Fadool et al.,
2004). Interestingly, Hennige et al. (2009) demonstrated that an
i.c.v. injection of the Kv1.3 pore blocker, margatoxin, similarly
elevated locomotor activity and increased cortical AP frequency.
Recently when provided access to voluntary running wheels,
the Kv1.3−/− mice had no marked irregularity in circadian
rhythm. The mice ran the same daily distance as WT mice,
but they ran at a lower velocity and in more frequent exercise
bursts (Gonzalez et al., unpublished data). When examined for
olfactory acuity, Kv1.3−/− mice showed a heightened sense of
smell in terms of both odorant discrimination and odor threshold
(Fadool et al., 2004). The Kv1.3 channel carries 60–80% of
the outward current in mitral cells of the OB (Fadool and
Levitan, 1998), which are the first order processing cells for
olfactory information. Not unexpectedly, deletion of Kv1.3−/− in
these neurons elicits an increase in the evoked firing frequency,
attributed to more spikes/AP cluster, a shortened interburst
interval, and also a depolarizing shift in the resting membrane
potential (Fadool et al., 2004, 2011). The olfactory circuitry
of Kv1.3−/− mice has a smaller number of axonal projections
from the olfactory epithelium to identified synaptic targets, or
glomeruli, and the projection is not mistargeted. The glomeruli,
however, are smaller and supernumerary (Biju et al., 2008).
Finally, the expression of G-protein coupled odor receptors
(ORs) is enhanced in the Kv1.3−/− mice, with a concomitant
increase in OR density in the ciliary processes that contain
this odorant transduction machinery (Biju et al., 2008). This
collective phenotype in the knockout mice reveals the broad
span of non-conducting functions of Kv1.3 channels, from energy
homeostasis, to ingestive behavior, to axonal targeting, and
sensory perception or odor tuning.
Because Kv1.3−/− mice exhibited altered ingestive behaviors
(Fadool et al., 2004), we and others challenged them with
modified-fat diets and discovered a resistance to diet-
induced obesity (DIO) (Xu et al., 2003; Tucker et al., 2012).
Moreover, when Kv1.3−/− mice were bred to homozygosity with
melanocortin-4 receptor-null mice (Tucker et al., 2008), which
have a disruption of the hypothalamic, anorexogenic pathway
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and are a model for genetic obesity, the resultant progeny had
reduced adiposity and body weight, attributed to increased
locomotor activity and energy expenditure. Interestingly, while
Kv1.3 has a selective distribution within the central nervous
system (dentate gyrus, OB, and olfactory cortex; Kues and
Wunder, 1992), its biophysical properties were first characterized
in T lymphocytes (Cahalan et al., 1985). Others have explored
the channel’s capacity to regulate either body weight or insulin
sensitivity (Xu et al., 2004; Upadhyay et al., 2013) by blocking
channel activity in the periphery. Intraperitoneal injection of
margatoxin, which blocks the vestibule of the Kv1.3 channel
(Knaus et al., 1995), was found to increase insulin sensitivity
in wildtype and genetic models of obesity, namely ob/ob and
db/db mice (Xu et al., 2004). A similar effect was discovered
as a result of a different channel blocker, ShK186, which was
effective in increasing peripheral insulin sensitivity in mice
that were fed an obesogenic diet of high fat and fructose
(Upadhyay et al., 2013). Beyond enhanced insulin sensitivity
in DIO mice, ShK-186 treatment also reduced weight gain,
adiposity, and fatty liver and activated brown fat to augment
oxygen consumption and energy expenditure. Although there
have been conflicting reports on the ability of the channel to
improve insulin sensitivity based upon the pharmacological
inhibition of peripheral Kv1.3 across different skeletal muscle cell
lines (Straub et al., 2011; Hamilton et al., 2014) and exploration
of the selectivity of Kv1.3 blockers themselves (Bartok et al.,
2014), peripheral targeting of the Kv1.3 channel remains a strong
therapeutic target for regulating diabetes, inflammation, and
other diseases (Choi and Hahn, 2010; Pérez-Verdaguer et al.,
2015).
One manner by which Kv1.3 is thought to promote insulin
sensitivity and glucose uptake is through the insulin-sensitive
glucose transporter type 4 (GLUT4) (Xu et al., 2004). Inhibition
or gene-targeted deletion of Kv1.3 stimulates glucose uptake and
translocation of GLUT4 in adipose tissue and skeletal muscle.
Because glucose (C6H12O6) is a polar molecule, its transport
across the plasmamembrane requires integral transport proteins.
Carriers for glucose were first isolated from the membranes
of HepG2, a hepatic cell line, as reviewed by Baly and Horuk
(1988). Since then, different families and classes of glucose
transporters have been identified in peripheral tissues as well as
in the brain. Glucose is transported across biological membranes
via glucose transporters (GLUTs) according to “an alternating
conformer model.” According to this model, glucose can bind
to one of two mutually-exclusive binding sites of the transporter,
either on the extracellular or the intracellular site. The glucose
transporter switches from one conformation to another to
release its substrate (Carruthers, 1990). GLUTs comprise 14
family members named in the order they were cloned, and
divided into three subfamilies: class I (GLUT1-4, and GLUT14),
class II (GLUT5, GLUT7, GLUT9, and GLUT11), and class III
(GLUT6, 8, 10, 12, and the myoinositol transporter HMIT1 or
GLUT13) (see Table 1). GLUTs exhibit diverse substrate and
tissue specificity, resulting in distinct functional characteristics.
Their sequences, however, are similar in that (1) 12 helices span
the plasma membrane with seven conserved glycine residues in
each helix, (2) the intracellular surface has several basic and acidic
residues, and (3) two tryptophan and two tyrosine residues are
conserved (Joost and Thorens, 2001).
It has been shown that loss of Kv1.3 translocates GLUT4, a
member of the family of facilitative glucose transporters (GLUTs)
or class I, in a calcium-dependent and insulin-independent
manner (Xu et al., 2004; Desir, 2005). In adipocytes, the
mechanism of translocation is thought to occur through a
PI3K-independent pathway consisting of depolarizing the plasma
membrane and increasing the intracellular Ca2+ concentration
(Li et al., 2006). The co-localization of GLUT4 and Kv1.3 centrally
has not been explored and the mechanism of glucose signaling
in the OB has only recently been investigated (Tucker et al.,
2013; Al Koborssy et al., 2014) for such an energy demanding
process as odor processing (Carter and Bean, 2009; Lecoq et al.,
2009, 2011). Kv1.3 currents can be modulated by metabolically
active (d-glucose) rather than inactive (l-glucose) glucose in a
dose-dependent manner that follows a bell-shaped curve (Tucker
et al., 2013). Using a slice preparation of the OB and current-
clamp configuration, we found that mitral cells of the OB could
be either excited or inhibited by glucose (Tucker et al., 2013). The
change in mitral cell excitability was linked to a changed latency
to first spike and alternation of the AP cluster length. Kv1.3−/−
mice were insensitive to glucose and unlike modulation by
phosphorylation, glucose-induced change in mitral cell activity
was rapid and reversible within the time course of a patch
recording. We now report the presence of GLUT4 and Kv1.3,
centrally, co-localized in themitral cell layer of the OB.Moreover,
using a heterologous expression system (HEK 293 cells), we are
able to increase the translocation of GLUT4 when the pore of
Kv1.3 (Delaney et al., 2014) is mutated to yield a non-conducting
channel. This suggests that a number of modulators of Kv1.3 that
can inhibit channel conductance (src, EGF, insulin, BDNF, glp-1,
Nedd4-2) (Holmes et al., 1996; Bowlby et al., 1997; Fadool et al.,
1997, 2000; Fadool and Levitan, 1998; Cook and Fadool, 2002;
Colley et al., 2009; Thiebaud et al., 2016; Velez et al., 2016), could
be poised to increase GLUT4 translocation and the utilization of
glucose by mitral cells of the OB.
While Kv1.3 channels do not exist in isolation in the plasma
membrane—they are part of a well-characterized scaffold of
proteins and adaptor proteins that act to interface signaling
cascades with the channel (Cook and Fadool, 2002; Marks and
Fadool, 2007; Colley et al., 2009)—the channels are not solely
restricted to this organelle. The channel is additionally highly
expressed in the inner mitochondrial membrane, or IMM, of
several cell types including lymphocytes (Szabo et al., 2005),
cancer cells (Leanza et al., 2012), and hippocampal neurons
(Bednarczyk et al., 2010). It is for this reason, and given the
metabolic and olfactory phenotypes of Kv1.3−/− mice, that we
undertook an ultrastructural analysis of mitochondria in the
OB. The IMM is home to many types of ion channels and
exchangers for a variety of cations and anions (Bernardi, 1999),
which maintain a negative membrane potential of the organelle.
The tightly controlled IMM permeability is critical for efficient
ATP production and a dysregulation of IMM permeability often
leads to cell death (Kim et al., 2003). It has been proposed that
potassium ion channels play an important role in the control
of the integrity of the IMM (Szewczyk et al., 2009) whereby
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TABLE 1 | Distribution of glucose transporters and Kv1.3 channel.
Transporter/Channel Experimental Model Technique Localization References
CLASS I GLUT1 Mouse IHC (gold particles) Asymmetric expression in cortex,
hippocampus, cerebellum, and OB
Dobrogowska and
Vorbrodt, 1999
GLUT1 and GLUT2 Mouse IHC and in situ
hybridization
Tanycytes in hypothalamus García et al., 2003
GLUT1, GLUT3, and GLUT4 Bovine, Rat Western blot, qPCR,
and ICC
Monocytes, olfactory bulb O’Boyle et al.,
2012; Al Koborssy
et al., 2014
CLASS II GLUT 5 Rat RNA blotting Small intestine, kidney, and brain Rand et al., 1993
GLUT7 Human, Rat Northern blot, IHC,
and Western blot
Small intestine, colon, testes, and
prostate in humans. Small intestine
and low expression in colon of rat
Cheeseman, 2008
GLUT9 Human Northern blot Highly expressed in kidney and liver.
Low levels of expression in lung,
leukocytes, & heart
Phay et al., 2000
GLUT11 Human, Xenopus oocytes Northern blot and
qPCR
Three splice variants: GLUT11-A in
heart, skeletal muscle and kidney.
GLUT11-B in kidney, adipose, and
placenta. GLUT11-C in adipose,
heart, skeletal muscle, and pancreas.
Scheepers et al.,
2005
CLASS III GLUT10 and GLUT12 Human, Mouse RT-PCR Adipose tissue: mature adipocytes
and stromal vascular cells
Wood et al., 2003
GLUT8 Mouse, Rat, Human Northern blot Highly expressed in human testes and
sperm cells. Low amounts detected
in several brain areas, skeletal
muscle, heart, and small intestine
Schmidt et al.,
2009
GLUT13 (HMIT1) Mouse, Xenopus oocytes Western blot,
Northern blot,
Immunofluorescence
Multiple brain areas; mostly in glial
cells but also present in neurons
Cura and
Carruthers, 2012
CHANNEL Kv1.3 Human cell line Patch-clamp
electrophysiology
Voltage-gated potassium channel first
characterized in T-lymphocytes
Cahalan et al.,
1985
Kv1.3 Rat In situ hybridization Dentate gyrus, OB, piriform cortex Kues and Wunder,
1992
Kv1.3 Human and mouse cell lines Western blot T-lymphocytes Cai and Douglass,
1993
Kv1.3 Rat cell culture, Mouse, Rat ICC and Patch-clamp
electrophysiology
Kv1.3 highly expressed in mitral cells
of olfactory bulb
Fadool and
Levitan, 1998;
Fadool et al.,
2000, 2004
Kv1.3 Rat IHC, RT-PCR,
immunofluorescence,
and immunoblotting
Kv1.3 expressed in both cortex and
medulla of kidney
Carrisoza-Gaytán
et al., 2010
IHC, immunohistochemistry; ICC, immunocytochemistry; OB, olfactory bulb; RT-PCR, reverse transcriptase PCR; qPCR, quantitative PCR.
substantial evidence has shown cardio- and neuro-protective
effects of targeting mitochondrial potassium channels (Szewczyk
and Marban, 1999; Busija et al., 2004; O’Rourke, 2004). The
mechanism of these effects has been linked to the mitochondrial
production of reactive oxygen species or ROS (Malinska et al.,
2010). Interestingly, it has been shown that oxygen/glucose
deprivation of microglia results in suppression of Kv1.3 currents
in a tyrosine phosphorylation signaling cascade, which can
be significantly attenuated by ROS scavengers (Cayabyab
et al., 2000). It is possible that mitochondrial Kv1.3 functions
could go beyond cytoprotection and involve ROS-dependent
energy metabolism. ROS signaling is usually considered to be
detrimental and damage-promoting, however, ROS can act as
signaling molecules regulating organismal homeostasis, stress
responsiveness, health, and longevity (Shadel and Horvath,
2015). ROS production is linked to the central control of whole
body metabolism (Shadel and Horvath, 2015). In fact, there is
considerable evidence showing that ROS can enhance insulin
sensitivity by oxidizing multiple signaling molecules (Mahadev
et al., 2001, 2004; Loh et al., 2009; Cheng et al., 2010), while long-
term excessive ROS may cause insulin resistance (Szendroedi
et al., 2012).
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Metabolic imbalance attributed to DIO has been shown to
disrupt the structure and function of the olfactory system.
When mice were challenged with high-fat or high-fat, high-
carbohydrate diets, the excess energy imbalance resulted in
marked loss of olfactory sensory neurons (OSNs), loss of
axonal projections to defined glomerular targets, reduced electro-
olfactogram amplitude, irregular AP firing frequency in mitral
cells of the OB, reduced olfactory discrimination ability, slowed
reward-reinforced behaviors, and disrupted reversal learning
(Fadool et al., 2011; Thiebaud et al., 2014). Insulin-induced Kv1.3
phosphorylation in the OB (Fadool and Levitan, 1998; Fadool
et al., 2000) was lost in DIO mice (Marks et al., 2009) and slices
from thesemice exhibited loss of insulinmodulation ofmitral cell
excitability, exemplifying a degree of insulin resistance for mitral
cell function in the obese state (Fadool et al., 2011). Obesity-
resistant Kv1.3−/− mice exhibited similar loss of OSNs to that of
WTmice while challenged with high-fat, high-carbohydrate diet,
but not when fed a high-fat diet. The Kv1.3−/− mice showed a
concomitant loss of olfactory discrimination and slowed reward-
reinforced behaviors only when challenged with the high-fat,
high-carbohydrate diet. Kv1.3−/− mice oddly showed improved
olfactory discrimination with the high-fat diet and showed
reversal learning capacity regardless of diet.
Herein, in an effort to further elucidate the mechanism of the
metabolic phenotype of Kv1.3−/− mice, we report the presence
of GLUT4 in the same OB neurolamina as the Kv1.3 channel and
explore the ultrastructure of mitochondria in the Kv1.3−/− mice.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee (IACUC) at the Florida
State University (FSU) under protocols #1124 and #1427, and
followed the guidelines set forth by the National Institutes of
Health (NIH) and the American Veterinary Medical Association
(AVMA). Mice were anesthetized with isoflurane (Aerrane;
Baxter, Deerfield, IL, USA) using the IACUC-approved drop
method and were then sacrificed by decapitation (AVMA
Guidelines on Euthanasia, June 2007).
Solutions
Phosphate-buffered saline (PBS) contained (in mM): 136.9 NaCl,
2.7 KCl, 10.1 Na2HPO4, and 1.8 KH2PO4 (pH 7.4). Phosphate-
buffered saline + Tween (PBST) contained 1x PBS and 0.1%
Tween. Hybridization buffer contained 0.5 M formamide, 0.25
M 20x SSC, 5 mg/mL torula yeast RNA, 50 mg/mL heparin
sodium salt, and 0.1% Tween. 20x SSC contained 3 mM sodium
chloride and 342 µM sodium citrate (pH 7.2). Blocking solution
for in situ hybridization contained 0.2% BSA in PBST. NTMT
contained (in mM): 100 Tris-HCl (pH 9.5), 25 MgCl2, 100
NaCl, and 0.1% Tween 20 (Cold Spring Harbor Protocols;
http://cshprotocols.cshlp.org/). Wash buffer contained (in mM);
25 Tris, 250 NaCl, 5 EDTA, and 0.1% Triton X-100 (pH
7.5). Phosphatase inhibitor mixture (PPI) contained 1 mM
phenylmethylsulfonyl fluoride, 10 µg/mL aprotinin, 1 µg/mL
leupeptin, and 1 µg/mL pepstatin. All salts and reagents were
obtained from Sigma Chemical (St Louis, MO, USA) or Fisher
Scientific, Inc. (Atlanta, GA, USA) unless otherwise stated.
Animal Care
All mice used in our study were adult C57BL/6J male mice
(000664 | Black 6; The Jackson Laboratory, Bar Harbor, ME,
USA). Mice were weaned at postnatal day 29 and singly housed
in conventional open cages at the FSU vivarium under a 12/12
h light/dark cycle with ad libitum access to food and water.
For ultrastructural studies, wild-type (WT) and Kv1.3−/− mice
(Xu et al., 2003; Fadool et al., 2004) were maintained on
either a control diet (CF; Purina 5001 Rodent Chow; 28.05%
kcal protein, 59.81% kcal carbohydrate, and 13.5% kcal fat;
Richmond,VA, USA) or a moderately high-fat condensed milk
diet (MHF; Research Diets D12266B; 16.8% kcal protein, 51.4%
kcal carbohydrate, and 31.8% kcal fat; New Brunswick, NJ, USA)
for a duration of 4 months.
In situ Hybridization
RNA Probes
RNA from the OB of WT and Kv1.3−/− mice was isolated
with Trizol reagent (Life Technologies, CA, USA). Total
RNA was phenol/chloroform extracted, precipitated with
isopropanol, washed with ethanol, and then dissolved in
ultra-pure distilled water. Total cDNA was obtained by
reverse transcription with oligo dT primer (Invitrogen,
Carlsbad, CA, USA). Targeted genes were amplified by
polymerase chain reaction using the following primers:
GLUT4 primers forward 5′-TCTCAGCTGCCTTCCGAC-
3′ and reverse 5′-TACCAAAGGCTCCCTCCC-3′; Kv1.3
primers forward 5′-CTTCGACGCCATCCTCTACTAC-3′ and
reverse 5′-AAGCTCAAAGGAGAACCAGATG-3′; TH primers
forward 5′-GATTGCAGAGATTGCCTTCC-3′ and reverse
5′-CCTGTGGGTGGTACCCTATG-3′. Kv1.3 and GLUT4
amplicons were cloned into pGEMT (Promega, Madison, WI,
USA). The vector was linearized with Sac I for Kv1.3 and Xba
I for GLUT4. Digoxigenin-UTP labeled RNA probes were
made according to the manufacturer’s specifications (Roche,
Indianapolis, IN, USA) using SP6 RNA polymerase. Tyrosine
hydroxylase (TH) RNA probe was generated as a positive control
(result not shown) (Cubells et al., 1995), and Kv1.3 probe was
applied to slices of Kv1.3−/− mice as a negative control.
In situ Hybridization
WT and Kv1.3−/− mice were perfused with 4%
paraformaldehyde (PFA), and the OBs were quickly dissected and
placed in the perfusion solution overnight at 4◦C. Thirty- micron
slices were cut on a microtome (Leica CM1850, Buffalo Grove,
IL, USA) and were left free floating in 100% methanol until use.
For labeling, free-floating slices were transferred to a nine-well
glass plate. Slices were first re-hydrated in a graded methanol
series diluted in PBS (75, 50, and 25%) for 5min each then 4
times with 100% PBST 0.1% for 5min each. Slices were digested
with 10mg/mL proteinase K dissolved in PBST for 15min,
followed by a 10-min rinse in PBST, a 20-min fixation with PFA,
and five rinses of 5min each in PBST. Slices were pre-hybridized
in hybridization buffer for 2 h at 60 ◦C, and then hybridized
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overnight with the probe at 60◦C. Probe concentration was
0.5 ng/µL and total volume applied was 300µL. The next day,
slices were first rinsed at 60◦C with graded dilutions of 2x SSC
in hybridization buffer (25, 50, 75, and 100%) 10min each,
then twice at 68◦C with 100% 0.2x SSC for 30min, followed
by 5-min rinses with graded dilutions (75, 50, 25, and 0%) of
0.2x SSC in PBST. PBST was then removed and replaced with
blocking solution for 2 h at 4◦C. Anti-digoxigenin Fab fragment
conjugated to alkaline phosphatase was added overnight at
4◦C. On day 3, slices were washed with blocking buffer then
NTMT. DIG-labeled RNA probes were immunodetected with
DIG Nucleic Acid Detection Kit (NBT/BCIP) according to the
manufacturer’s protocol (Roche). Slices were finally mounted on
microscopic slides before visualization.
Electron Microscopy
All electron microscopy reagents were purchased from Electron
Microscopy Sciences (EMS; Hatfield, PA, USA) unless otherwise
noted. Following maintenance on modified diets, mice were
perfused through the heart with PBS then with 4% PFA. OBs
were quickly dissected and fixed in 4% PFA overnight, followed
by infiltration with 10, and 30% sucrose in PBS at 4◦C. Coronal
OB sections were cut to 100 µm thickness on a vibratome (Leica
Model 1000, Wetzlar, Germany), and transferred to a 24-well
plate. Slices were washed three times with PBS, and then were
incubated in 2% osmium tetroxide at room temperature for an
hour. This was followed by a series of graded alcohol washes
with 50% ethanol (EtOH) and 70% EtOH for 10min each. The
sections were further incubated with 1% uranyl acetate in 70%
EtOH for 1 h before being dehydrated sequentially in 70, 90
and twice in 100% EtOH for 10 min each. After dehydration,
sections were washed twice in propylene oxide for 10 min after
which they were embedded in EMbed 812 Resin /propylene oxide
(1:1) overnight on a rotary shaker in a fume hood to allow
the propylene oxide to gradually evaporate. The following day,
sections were infiltrated twice with fresh Epon for 12 h each on
a shaker. Next the sections were flat embedded in fresh Epon
between ACLAR plastic sheets (EMS) and polymerized in a
60◦C oven over 3 days. ACLAR sheets were examined with a
Nikon SMZ1000 stereoscopic microscope (Melville, NY, USA)
and areas of the Epon film containing stretches of intact OB
tissue layers were excised and remounted on Epon blocks with
Scotch Super Glue Liquid (3M). Silver-gold sections (90–100 nm)
were cut with a Leica Ultracut E microtome (Buffalo Grove,
IL, USA) and mounted on 3.05 mm copper hexagonal mesh
grids. The grids were post-stained with 2% uranyl acetate in
ddH2O for 10 min followed by 4% Reynold’s lead citrate for
5 min. Images were recorded on a FEI CM120 transmission
electron microscope (Hillsboro, OR, USA) using a Tietz Tem-
Cam F224 slow scan CCD camera. Mitochondrial counts were
taken from a series of low magnification electron micrographs
totaling ∼2000 µm2 for each experimental condition. Within
each 51.5 µm2 field of view, all mitochondria were counted.
Mitochondrial area and circularity (4pi× area / perimeter2) were
quantified using Photoshop CS4 software (Adobe, San Jose, CA,
USA). Approximately 40 fields of view from each experimental
condition (CF+/+, MHF+/+, CF−/−, MHF−/−) were analyzed
as sampled from 3 mice in each condition.
cDNA Constructs
The expression vectors were mammalian-based and contained
the cytomegalovirus (CMV) promotor upstream from the
coding region. Kv1.3 was ligated into the Invitrogen vector
pcDNA3 at the unique Hind III site of the multiple coding
region as previously described (Fadool et al., 2000). A non-
conducting mutant Kv1.3 channel (W386F Kv1.3) was generated
by site-directed mutagenesis as previously described (Holmes
et al., 1997). The cDNA for GLUT4-myc-eGFP was generously
provided by Dr. Jeffrey E. Pessin (Albert Einstein College of
Medicine, Bronx, NY, USA).
Cell Maintenance and Transient
Transfection
Human embryonic kidney (HEK) 293 cells were handled
according to the guidelines of the European Center for the
Validation of Alternative Methods Task force based on the
Guidance on Good Cell Culture Practices (GCCP; Coecke et al.,
2005). Cells were grown at 37◦C in modified Eagle’s minimum
essential media (MEM; Gibco/Life Technologies, Carlsbad,
CA, USA) supplemented with 2% penicillin/streptomycin
(Sigma-Aldrich) and 10% fetal bovine serum (Gibco/Life
Technologies). Cells were grown to 75–80% confluency for 3–
4 days, after which cDNA was introduced with lipofectamine
(Thermo Fisher Scientific, #18324-012; Waltham, MA, USA)
as previously described (Marks and Fadool, 2007). Briefly,
3 µg of each cDNA construct was complexed with 18 µl
of lipofectamine for 30min in Opti-MEM (Gibco), after
which the cDNA/lipofectamine/Opti-MEM mixture was applied
to HEK293 cells in a 60mm dish for 5 h before the
transfection was stopped by replacing with MEM. Proteins were
immunoprecipitated 2 days post transfection.
Immunoprecipitation and Western Blot
Cells were lysed and prepared for immunoprecipitation following
a modification of procedures by Colley et al. (2007). Two
days post transfection, HEK 293 cells designated for detection
of surface GLUT4 were first incubated for 30 min at 37◦C
with 1:300 c-myc antibody (9E10 clone, Roche), then washed
three times with sodium orthovanadate diluted in PBS. Cells
were then lysed in ice-cold PPI mixture for 30min. The
lysates were clarified by centrifugation at 14,000 g for 10min
at 4◦C and the supernatant rotated overnight at 4◦C on a
Roto-Torque slow speed rotary (model 7637; Cole Palmer,
Vernon Hills, IL). The immunoprecipitated protein harvested
the next day with 3 mg/ml Protein A-Sepharose (GE Healthcare,
Pittsburgh, PA, USA). To collect total GLUT4, cells were lysed
first with PPI and then precleared with protein Sepharase
A for 3 h before anti-myc (1:400; 9E10 clone, Roche) was
added overnight to the whole-cell lysate. The next day, protein
Sepharose A was added again to the immunoprecipitated
proteins for 3 h, followed by 4 wash steps using centrifugation
at 14,000 g (4◦C) for 10min each with wash buffer (see section
Solutions).
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Immunoprecipitated proteins from whole-cell or surface
detection of GLUT4 were separated on 10% acrylamide
sodium dodecyl sulfate (SDS) gels and electro-transferred to
nitrocellulose for Western blot analysis as previously described
(Colley et al., 2007). Blots were blocked with 1% nonfat dry
milk (Biorad Laboratories, Hercules, PA, USA), and incubated
overnight at 4◦C in primary antibody against c-myc (1:700)
then with secondary antibody (goat anti-mouse; 1:3000; Sigma
A2304) for 90 min at room temperature. Protein bands were
visualized using enhanced chemiluminescence Western blotting
detection reagent (ECL; GE Healthcare) exposure on Fuji RX
film (Fisher Scientific). A Hewlett-Packard Photosmart Scanner
(model 106–816, Hewlett Packard, San Diego, CA) was used
in conjunction with Quantiscan software (Biosoft, Cambridge,
England) to quantify the densitometry of protein bands revealed
on the film autoradiographs.
Statistical Analysis
All data are reported as the mean (± s.d.). Significantly-different
means were determined by a one-way analysis of variance
(ANOVA) due to multiple comparison design of all experiments.
A Bonferoni post-hoc test was applied for protein biochemistry
experiments and a Student Newman Kuels (snk) was applied for
electron microscopy experiments. Different length vertical lines
represent significantly different post-hoc comparison.
RESULTS
mRNA of GLUT4 and Kv1.3 are
Co-localized in Mitral Cells of the Olfactory
Bulb
We have previously demonstrated that mitral cells are glucose-
sensitive and that modulation of AP firing frequency is
dependent upon Kv1.3 (Tucker et al., 2010, 2013). GLUT4
mRNA is expressed in 75% of glucose-sensing neurons of the
ventromedial nucleus of the hypothalamus (Kang et al., 2004).
We therefore hypothesized that GLUT4 would be localized to
the mitral cell layer where Kv1.3 channels carry 60–80% of
the outward current in these primary output neurons (Fadool
and Levitan, 1998). mRNA expression of GLUT4 was examined
by in situ hybridization with digoxigenin-labeled riboprobes.
A robust expression of GLUT4 transcripts was found in the
soma of mitral cells within the mitral cell layer (ML) from WT
mice (Figure 1). A faint labeling was observed in the granule
cell layer (GCL) and a few periglomerular cells (PG) expressed
GLUT4 mRNA. The expression pattern for GLUT4 was similar
in Kv1.3−/− mice, suggesting that the loss of Kv1.3 channel did
not affect transporter transcript expression. The Kv1.3 mRNA
transcript was also robustly visualized in the ML of WT mice in
nearly every mitral cell that was examined. Kv1.3 mRNA was also
visualized in PG cells to a greater extent than that of the GLUT4
probe. An absence of Kv1.3 mRNA labeling was observed in
Kv1.3−/− across all neural lamina (Figure 1, bottom). A similar
absence of labeling was found for slices where the probes were
omitted (data not shown).
FIGURE 1 | Kv1.3 and GLUT4 mRNA are expressed predominantly in
the glomerular and mitral cell layers of the olfactory bulb. Light
photomicrographs containing tissue sections of wildtype (WT+/+; left) and
Kv1.3-null mice (Kv1.3−/−; right) olfactory bulbs labeled with GLUT4 (GLUT4
probe; top) or Kv1.3 (Kv1.3 probe; bottom). Note that GLUT4 mRNA is
expressed predominantly in the mitral cell layer (ML) in both WT and Kv1.3−/−
mice, whereas Kv1.3 mRNA is localized to both the glomerular layer (GL) and
ML. GL, glomerular layer; EPL, external plexiform layer; ML, mitral cell layer;
GCL, granule cell layer.
GLUT4 Translocation is Facilitated by
Blocking Kv1.3 Conductance
Mice with genetic deletion of Kv1.3 are resistant tomodulation by
glucose (Tucker et al., 2013). Kv1.3 serves as an insulin receptor
(IR) kinase substrate, and its activity can be inhibited by tyrosine
phosphorylation (Fadool et al., 2000). Xu et al. (2004) found that
genetic or pharmacological blockade of Kv1.3 exerted the same
effect as insulin whereby GLUT4 translocation to the membrane
of adipocytes and skeletal muscles was increased. Kv1.3 inhibition
enhances GLUT4 translocation in adipocytes through a PI3K-
independent mechanism consisting of depolarizing the plasma
membrane and increasing intracellular Ca2+ concentration (Li
et al., 2006). To prove that Kv1.3 activation serves as molecular
trigger of GLUT4 translocation to the membrane, HEK 293
cells were transiently transfected with the cDNA coding for
GLUT4 plus wildtype or a pore mutant Kv1.3 channel. W386F
Kv1.3 is a construct whereby a threonine is substituted for a
phenylalanine and results in the translation of a non-conducting
channel (Holmes et al., 1997; Delaney et al., 2014). Whole-
cell or surface-labeled GLUT4 was visualized using anti-c-myc
directed against a myc extracellular, epitope tag on GLUT4
(Figure 2A). Whole-cell lysates showed a strong label for
total GLUT4 cell expression (Figures 2B,C). GLUT4 + Kv1.3
yielded a significantly lower total receptor cell expression that
was increased when the W386F Kv1.3 was substituted in the
transfection scheme [significantly different, one-way analysis
of variance (ANOVA) with Bonferoni’s post-hoc test, F(2,18) =
5.032, p= 0.0184]. Immunoprecipitation (IP) was used to isolate
the surface-labeled GLUT4 from total receptor cell expression
(Figures 2D,E). The IP strategy revealed very little GLUT4 at
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the plasma membrane during a static state, consistent with its
known intracellular storage pool reported by Li et al. (2009).
However, a consistent expression of GLUT4 was found in
the Kv1.3 co-transfection condition and a strong increase in
receptor expression was observed when Kv1.3 was substituted
by W386F Kv1.3 [significantly different, one-way ANOVA with
Bonferoni’s post-hoc test, F(2,12) = 6.242, p= 0.0139]. Our results
indicate that changes in Kv1.3 conductance produced by pore
mutagenesis upregulates GLUT4 translocation to the membrane
surface. Such regulated receptor membrane availability would
reflect the capacity to modify glucose utilization at any given
time.
Kv1.3−/− Mice have Smaller Mitochondria
that are Resistant to Morphological
Changed Induced by Diet-Induced Obesity
Elevated plasma glucose after a meal activates mitochondrial
oxidative phosphorylation in pancreatic cells to increase ATP
release and insulin secretion. A chronic rise in glucose, such as
in diabetic or obese patients, has caused mitochondrial atrophy,
which suggests an important connection between mitochondria
and metabolic imbalance (Gerbitz et al., 1996). Several potassium
channels contribute to mitochondrial function including Kv1.3
(Bednarczyk, 2009). We decided to investigate the change in
mitochondrial morphology in the OB of WT and Kv1.3−/− mice
that have been challenged with a MHF vs. CF diet.
Electron micrographs showing the abundance and size
of mitochondria examined within the cell bodies of mitral
cells are found in Figures 3A,B, respectively (low and higher
magnification). The number, cross-sectional area, and circularity
index of mitochondria from 40 fields of view were quantified
from three mice in each of the four conditions (Figures 3C–E).
For control fed mice, there was no change in the number of
mitochondria across the genotypes [number: one-way ANOVA,
F(3, 161) = 4.925, p = 0.0027, Student Newman Keuls’s (snk)
post-hoc test CF+/+ vs. CF−/−, p ≥ 0.05], however the cross-
sectional area was larger and circularity index was less in the WT
mice compared with that of the Kv1.3−/− mice [area: one-way
ANOVA, F(3, 305) = 51.36, p ≤ 0.0001, snk post-hoc test CF
+/+
vs. CF−/− significantly different, p ≤ 0.0001; circularity index:
one-way ANOVA, F(3, 302) = 8.178, p ≤ 0.0001, snk post-hoc
test CF+/+ vs. CF−/− significantly different, p ≤ 0.05]. When
WT mice were challenged with a MHF diet, the mitochondrial
cross-sectional area but not the circularity index became enlarged
[area: one-way ANOVA, F(3, 305) = 51.36, p ≤ 0.0001, snk post-
hoc test CF+/+ vs. MHF+/+ significantly different, p ≤ 0.0001;
circularity index: one-way ANOVA, F(3, 302) = 8.178, snk post-
hoc test CF+/+ vs. MHF+/+, p ≥ 0.05] and the abundance of
mitochondria decreased [number: F(3,161) = 4.925, p = 0.0027,
snk post-hoc test CF+/+ vs. MHF+/+ significantly different,
p ≤ 0.05]. In contrast, a MHF-diet challenge did not affect
mitochondria number, area, or circularity in the Kv1.3−/− mice
(one-way ANOVA, snk post-hoc test, p ≥ 0.05). These data
provide evidence that diet high in fat changes the morphology of
mitochondria in the OB, and that gene-targeted deletion of Kv1.3
precludes these effects.
DISCUSSION
The voltage-gated Shaker potassium channel Kv1.3 is a key
contributor in regulating body weight, metabolism, and energy
homeostasis. Fewer data are reported elucidating specific
potential molecular mechanisms linking Kv1.3 kinetics and
energy balance. Herein we provide new evidence for co-
localization of Kv1.3 and the glucose transporter type 4 (GLUT4)
in the mitral cell layer of the OB. We further demonstrate
that GLUT4 is a possible substrate for Kv1.3 activation whereby
functional Kv1.3 increases GLUT4 expression on the membrane
and Kv1.3 current suppression strongly upregulates GLUT4
transport from intracellular storage to the plasma membrane.
Additionally, we show that gene-targeted deletion of Kv1.3
channel changes mitochondrial shape and reduces their size.
Moreover, WT mice that are challenged with a MHF-diet exhibit
a decrease in number of mitochondria within the mitral cells of
the OB whereas those from Kv1.3−/− mice do not demonstrate
such loss. Mitochondria within Kv1.3−/− mice are also resistant
to increase in size followingMHF-challenge, which is observed in
WT mice.
As summarized in Table 1, GLUT4 is expressed in
several discrete brain regions such as the hypothalamus,
the hippocampus, the cerebellum, and the amygdala. GLUT4 in
the brain is mainly neuronal, and localizes on dendrites or on
the membranes of transport vesicles, Golgi apparatus, and the
rough endoplasmic reticulum (Kobayashi et al., 1996; Leloup
et al., 1996; McCall et al., 1997; El et al., 1998; Choeiri et al.,
2002). In the OB, GLUT4 proteins are localized on the dendritic
terminals of mitral/tufted cells at the level of glomeruli, which
are sites of synaptic connectivity between the axons of OSNs and
mitral cells, and in the nuclei of periglomerular cells (Sharp et al.,
1975). Our in situ hybridization results indicate that GLUT4
and Kv1.3 transcription occurs in the cell bodies of mitral cells
and interneurons before being translated and recruited at the
synapse for glucose-based modulation of olfactory information.
Interestingly, Sharp and collaborators also found that GLUT4
protein was co-localized with IR on mitral cells (Sharp et al.,
1975, 1977). This is highly consistent with our characterization
of IR modulation of Kv1.3 via tyrosine phosphorylation on the
N- and C-terminal aspects of the channel, and our finding of
co-localization of the channel with the kinase in mitral cells
(Fadool et al., 2000). Because our previous electrophysiological
data demonstrate nearly all mitral cells are insulin sensitive
(Fadool et al., 2011), combined with our current gene expression
data and the protein data from the Sharp laboratory (Sharp
et al., 1975, 1977), it is highly plausible that all three signaling
molecules are contained within mitral cells (Figure 4). Although
it remains to be shown if all mitral cells are homogeneous
in their expression of Kv1.3/GLUT4/IR or whether there is a
degree of heterogeneity across this population of first order
neurons (Angelo et al., 2012; Padmanabhan and Urban, 2014),
the modeled signaling interactions could influence glucose
sensing, and concurrently, electrical signaling, by mitral cells.
Decreased Kv1.3 activity evokes translocation of GLUT4 to the
membrane to permit glucose uptake and the end production of
ATP. In our model, we demonstrate two known modulators of
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FIGURE 2 | GLUT4 is expressed intracellularly and then translocates to the plasma membrane following block of Kv1.3 channel achieved by
site-directed mutagenesis of the pore. (A) Model of heterologous co-expression of a non-conducting Kv1.3 channel (W386F Kv1.3) and an extracellular
epitope-myc tagged GLUT4 transporter that becomes translocated to the plasma membrane. (B) Western blot of lysates harvested from HEK293 cells transfected
with K: Kv1.3 cDNA; W: mutant W386F Kv1.3 cDNA; G: GLUT4-myc cDNA. Blots were probed with myc antibody (anti-myc) to visualize labeling of all GLUT4 in a
whole-cell preparation. (C) Bar graph of the normalized pixel immunodensity of the quantified bands for 7 such blots as represented in (B). * = one-way analysis of
variance (ANOVA), Bonferoni post-hoc test, p ≤ 0.05. Different length vertical lines represent significantly different post-hoc comparison. (D,E) Same as (B,C) but
samples were surface immunoprecipitated (IP) with myc antibody (anti-myc) and then labeled with anti-myc to visualize labeling of surface GLUT4. Input (lysates) were
labeled with actin antibody (anti-actin) to standardize equal loading.
Kv1.3 activity that are related to incretin hormones (glycogen-
like peptide signaling and IR kinase), which decrease Kv1.3
conductance through either a confirmed (Fadool and Levitan,
1998; Fadool et al., 2000, 2011) or suspected (Thiebaud et al.,
2016) phosphorylation (P) of the channel. Our mutagenesis data
directly demonstrate that blocked conduction of Kv1.3 current is
solely capable of GLUT4 translocation and this is consistent with
earlier pharmacological experiments from the Desir laboratory
that applied known potassium channel blockers to visualize
surface expression of GLUT4 by immunocytochemistry (Xu
et al., 2004). Because our HEK cell model expresses only a
few components of the IR signaling cascade (Thomas and
Smart, 2005) and our experiments were performed without the
hormone insulin, our biochemical data demonstrate the ability
of Kv1.3 and GLUT4 to interact without the necessity of insulin
to either translocate GLUT4 or alternatively to phosphorylate
Kv1.3. We conjecture that in native mitral cells, insulin could
induce GLUT4 translocation either through direct IR activation
or through Kv1.3 inhibition caused by IR phosphorylation
(blue and red dashed lines, respectively; Figure 4). Our model
could include downstream signaling well characterized in
the periphery, however, the existence of these parallels in the
CNS is not known. For example, Kv1.3 inhibition enhances
GLUT4 translocation in adipocytes through a PI3K-independent
mechanism consisting of depolarizing the plasma membrane
and increasing intracellular Ca2+ concentration (Li et al., 2006).
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FIGURE 3 | Kv1.3−/− mice have smaller mitochondria in the mitral cell layer of the OB, which do not exhibit an increase in volume when challenged
with moderately-high fat diet (MHF). Photomicrographs acquired from the mitral cell layer of the OB of wildtype (+/+) and Kv1.3-null mice (–/–) maintained on
MHF vs. CF for 4 months. (A) Low and (B) higher magnification. Bar graph or box blot representing (C) mean number, (D) cross-sectional area, and (E) circularity
index of mitochondria collected across 40 fields of view for 3 mice. Data represent mean +/− s.d. for the bar graph, or mean (line), 25/75% quartile (box) and 5/95%
(whiskers) for the box plot. Significantly different, one-way ANOVA, Bonferoni’s post-hoc test, ****p ≤ 0.0001; ***p ≤ 0.001, **p ≤ 0.01; *p ≤ 0.05.
GLUT4 translocation to the membrane is classically facilitated by
insulin binding to its receptor, which triggers PI3K-dependent
or -independent pathways (Hoffman and Elmendorf, 2011).
Another interesting caveat is that GLUT4 expression in the OB
seems to be modulated by the feeding state. Postprandially when
glucose levels in the blood are high, GLUT4 is expressed on
the plasma membrane of dendritic processes. GLUT4 in fasted
rats however, is internalized into the cytoplasm (Al Koborssy
et al., 2014) even though insulin levels in the OB are shown to
be 15 fold higher in the fasting state (Fadool et al., 2000). Our
biochemical data point to a role of Kv1.3 in controlling GLUT4
expression on the membrane but more evidence is needed to
prove that this modulation could bypass IR kinase in vivo.
Because Kv1.3−/− mice have an increased locomotor activity
and metabolism, a change in mitochondrial shape might be
anticipated. Our ultrastructural data demonstrate that control fed
Kv1.3−/− mice have an altered circularity shape compared with
similarly fed WT mice. Additionally, the cross-sectional area of
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FIGURE 4 | Schematic diagram showing cell signaling interactions of plasma membrane Kv1.3 (Kv1.3) and potential interplay with mitochondrial Kv1.3
(mKv1.3). Glycogen-like peptide (GLP-1) and insulin are two signaling hormones that block Kv1.3 current. The channel (red) is known to be a substrate for insulin
receptor (IR) kinase (blue) on the N- and C-terminal aspects of the channel protein (Y111-113, Y137, Y479). Insulin-induced phosphorylation (P) of Kv1.3 (blue line)
decreases Kv1.3 current amplitude by decreasing Propen of the channel. GLUT4 is typically translocated to the membrane upon insulin activation (blue dashed line)
but upon block of Kv1.3 conductance, can also be translocated (red dashed line). Metabolism of glucose establishes the H+ gradient and the production of ATP via
the electron transport chain (ETC). Maintenance of the ionic environment is dependent upon influx of K+ through mKv1.3 and mKATP and the balance provided by
efflux via the K+/H+ exchanger. The ATP energy source could be used for the GLP-1R triggered conversion of ATP to cAMP through adenylase cyclase to increase
potential PKA activity (?). Metabolic factors that decrease Kv1.3 ion channel activity increase the AP firing frequency in mitral cells that is thought to provide odor
quality coding of olfactory information. OMM, outer mitochondria membrane; IMM, inner mitochondria membrane; IMS, inter membrane space.
the mitochondria is smaller in the Kv1.3−/− regardless of dietary
treatment. Neuronal mitochondria typically have cristae that
form a network of anastomosing tubes and the number of cristae
is correlated with the level of aerobic activity and associated
ATP production (Lehninger, 1982). While our analysis did not
quantify this sub-organelle structure, qualitatively the cristae
from the WT mice appeared to be more longitudinally arranged.
During high rates of metabolism, the mitochondrial membranes
can become condensed due to structural changes of the IMM and
matrix, as opposed to orthodox or “idling” mitochondria that are
not actively respiring (Lehninger, 1982). This type of shrinking
does not appear to be the cause of smaller mitochondria in the
Kv1.3−/− because the outer mitochondrial membrane (OMM)
is observed closely juxtaposed to the IMM and cristae. Future
functional studying of mitochondria from Kv1.3−/− mice are
needed to test the idea that the more condensed mitochondrial
volume might contribute to increased TEE. Interestingly in the
rat OB, the respiratory control ratio that measures mitochondrial
activity is 2x higher that in the hypothalamus (Benani et al.,
2009) and is in accordance with the high energy demand of the
glomeruli (Nawroth et al., 2007). What is also of interest for
mitochondria in the OB is the high expression of GLUT4 in this
region and the total energy budget for olfactory discrimination.
Odor-evoked oxidative metabolism of OB synaptic transmission
is energetically demanding and is tightly correlated to capillary
density (Lecoq et al., 2009).
The challenge of a MHF-diet did not decrease the number or
increase cross-sectional area of mitochondria in the Kv1.3−/−
mice as it did in the WT mice. This is very intriguing given
that mitochondria are highly dynamic in morphology and
abundance. In liver, short-term challenge (21 day) with a high-
fat diet causes a decrease in proteins of the electron transport
chain and transporters/exchangers of the IMM, but does not
cause a change in mitochondrial volume (Kahle et al., 2015).
The influx of potassium across the IMM (Figure 4) through
both mKv1.3 and mKATP could cause an increase in volume
changes of the mitochondria if not tightly counterbalanced by
the H+/K+ antiport exchanger (Garlid, 1996). One role of the
H+/K+ antiport exchanger is to counterbalance the influx of K+
that allows the high membrane gradient required for oxidative
phosphorylation and thereby acts to provide volume homeostasis
(Garlid and Paucek, 2003). In the absence of Kv1.3, there may be
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less K+ influx, leading to smaller mitochondria. In the condition
of long-term (4 months) MHF-diet and precipitated DIO, the
WT mice could have dysfunction in IMM ion transport resulting
in increased volume or swelling. Such ionic imbalance could lead
to unhealthymitochondria, whichmight undergomitophagy and
lead to a loss in mitochondrial density or abundance such as
we observed. The subsequent lack of volume change or loss of
number in the fat-fed Kv1.3−/− mice could be either attributed
to less initial K+ influx or changed fatty-acid metabolism that
is also linked to organelle volume (Garlid, 1996) and would be
anticipated to be reduced in the thin, obesity resistant mice.
Whether mitochondrial dysfunction is linked to glucose
intolerance and insulin resistance is a topic of intensive research
and current debate (see review, Montgomery and Turner,
2015) but certainly a greater number of mitochondria permit
greater ATP production and a reduced number of mitochondria
are found during periods of quiescence. Typical to what we
observed in the DIO wildtype mice, a reduced number of
mitochondria was associated with larger individual organelles.
Although our ultrastructural data do not allow us to discern if
the larger mitochondria had impaired function, by deduction,
the fatty diet either decreased mitochondrial biogenesis or
increased mitophagy to yield a decreased mitochondrial density
in the obese mice. The fact that loss of Kv1.3 channel
alters mitochondria shape and prevents increased volume of
mitochondria when challenged with MHF suggests an alteration
of normal dynamics of the organelle and associated fission and
fusion proteins. Similar effects of high-fat diet on mitochondrial
function have been observed in the central nervous system
(Petrov et al., 2015). For example, Parton et al. (2007)
attributed loss of glucose sensing by pro-opiomelanocortin
(POMC) neurons of the hypothalamus in DIO mice to the
mitochondrial uncoupling protein 2 (UCP2). Genetic deletion or
pharmacological inhibition of UCP2 was able to restore glucose
sensing in the obese mice, underscoring the role of mitochondrial
dysfunction and altered ATP production in DIO.
One of the earliest changes in the development of insulin
resistance attributed to DIO is ectopic lipid accumulation
(Turner et al., 2013). In response to excess lipid availability
in the wildtype DIO mice, increase reactive oxygen species
(ROS) such as superoxides, hydroxyl radicals, and hydrogen
peroxide could have been elevated (i.e., Paglialunga et al., 2015).
Interestingly, Kv1.3 can be regulated by these types of second
messengers. Phosphorylation of Kv1.3 on four serine residues by
PKA and PKC is known to increase Kv1.3 activity to maintain
a negative membrane potential (Chung and Schlichter, 1997a,b).
As ATP is depleted below basal intracellular levels, the channel
exhibits reduced peak current amplitude and a shift in voltage
dependence. Application of ROS scavengers alleviates Kv1.3
phosphorylation to decrease the membrane potential (Cayabyab
et al., 2000).
Plasma membrane bound Kv1.3 and mitochondrial Kv1.3
could influence or detect metabolic state at the level of
the OB through channel neuromodulation and down-stream
signaling cascades that could modify excitability. Insulin and the
incretin hormone, GLP-1, can phosphorylate Kv1.3 at the plasma
membrane, decrease Kv1.3 current and upregulate GLUT4
translocation to the membrane to facilitate glucose metabolism.
In turn, the activity of mitochondrial Kv1.3 is linked to ROS
and ATP production that regulate channel phosphorylation and
conductance. Future targeted regulation of Kv1.3 in the OB could
reveal the ability of this brain region to detect and regulate
metabolic state by changing membrane excitability based on
nutritional needs. The extent by which the mitral cell plasma
and mitochondrial membrane activity interplays in detecting the
chemistry of metabolism and olfactory coding utilizing Kv1.3 is
a novel future trajectory in understanding brain energy sensing
and dysfunction following obesity.
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